Protara Therapeutics, Inc. (TARA) stock
TARANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30
$2.34+0.02 (+0.86%)
Close on Nov 18, 2026Market cap $138.28MP/E –Yield –
Protara Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Protara Therapeutics's total debt was $0 at Dec 31, 2021. For fiscal 2021 it was $0.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $0 | – |
| FY2020 | Dec 31, 2020 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2021 | Dec 31, 2021 | $0 | -100.0% |
| Q4 FY2020 | Dec 31, 2020 | $0 | – |
| Q3 FY2020 | Sep 30, 2020 | $370.79K | – |
| Q2 FY2020 | Jun 30, 2020 | $926.98K | – |
| Q1 FY2020 | Mar 31, 2020 | $1.30M | – |
See a number that looks wrong?